EcoDrugPlus

Ensembl ID : ENSACIG00000014169
Gene Symbol: -
Cross references: -
406 Possible Orthologues:

Ensembl ID : ENSACIG00000000925
Gene Symbol: -
1 Cross references
204 Possible Orthologues:

Ensembl ID : ENSACIG00000012134
Gene Symbol: PSEN1
1 Cross references
202 Possible Orthologues:

Ensembl ID : ENSACIG00000014883
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSACIG00000013987
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSACIG00000021235
Gene Symbol: -
Cross references: -
164 Possible Orthologues:

Ensembl ID : ENSACIG00000013064
Gene Symbol: PSMD11B
1 Cross references
215 Possible Orthologues:

Ensembl ID : ENSACIG00000005651
Gene Symbol: PARP1
1 Cross references
209 Possible Orthologues:

Ensembl ID : ENSACIG00000021366
Gene Symbol: -
Cross references: -
167 Possible Orthologues:

Ensembl ID : ENSACIG00000008351
Gene Symbol: -
Cross references: -
148 Possible Orthologues:

Ensembl ID : ENSACIG00000007077
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSACIG00000007123
Gene Symbol: -
Cross references: -
191 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).